“…In the present study [3], freedom from RV-PA reintervention at 3 years for initial RV-PA connection was found in 75.0% of patients treated with homografts, 66.7% of those who underwent direct connection (réparation à l'étage ventriculaire [REV] procedure), 46.7% of those who received a valveless polytetrafluoroethylene (PTFE) conduit, 40.0% of those who received a valved PTFE conduit, and 20.0% of those treated with a Contegra conduit. Although freedom from RV-PA reintervention was not significantly different according to the type of conduit, homograft, REV, and valveless conduits tended to be more durable, whereas valved nonhomograft conduits tended to be less durable.…”